Infectious Disease Reports is a premier open-access journal published by MDPI, dedicated to advancing the field of infectious diseases. Since its inception in 2009, this journal has established itself as a significant platform for disseminating cutting-edge research, reviews, and case studies, critical for global health. With a commendable Q2 ranking in the category of Infectious Diseases and a Scopus rank of #140 out of 344, it is recognized for its impactful contributions to medical research, holding a 59th percentile in its field. The journal aims to provide comprehensive insights into various dimensions of infectious diseases, ranging from epidemiology to novel treatment modalities. As an open-access publication, Infectious Disease Reports ensures that its articles are freely available to a wide audience, fostering collaborative efforts among researchers, healthcare professionals, and students worldwide. With its ongoing commitment to excellence, the journal plays an essential role in shaping the future of infectious disease research.

Infektsiya i Immunitet, published by the esteemed SANKT-PETERSBURG-NIIEM IMENI PASTERA, is a prominent open access journal that has been disseminating vital research findings since 2011. Focusing on the fields of immunology and infectious diseases, this journal serves as a critical platform for scholars, professionals, and students in the Russian Federation and beyond. With an ISSN of 2220-7619 and an E-ISSN of 2313-7398, it currently holds a Q4 ranking in 2023 for both Immunology and Infectious Diseases, along with notable quartile standings in related fields. Despite its emerging status, Infektsiya i Immunitet provides valuable insights and contributes to the growing discourse on immunity and infection prevention strategies, making it an essential resource for those invested in advancing knowledge and enhancing public health outcomes. Researchers can conveniently access its wealth of articles and studies that bridge theoretical understanding and practical implications in their respective domains.

The Revista Espanola de Quimioterapia, published by the SOCIEDAD ESPANOLA QUIMIOTERAPIA, is a pivotal open-access journal that has been advancing the field of clinical microbiology and pharmacology since its inception in 1989. With an E-ISSN of 1988-9518, this journal caters to a diverse audience of researchers, healthcare professionals, and students, providing them with critical insights into the latest developments in medicinal chemistry and therapeutic strategies. Located in Madrid, Spain, the journal reflects the rigorous academic standards of its associated institutions, contributing significantly to the translation of research into clinical practice. Achieving a Q3 ranking in the fields of Medicine, Microbiology, and Pharmacology in 2023 attests to its growing influence and relevance in the scientific community, making it a vital resource for those engaged in the quest for innovative solutions to pressing healthcare challenges. The journal prides itself on its commitment to maintaining an open-access model since 2018, ensuring that vital research is freely accessible to foster greater knowledge sharing and collaboration within the global scientific community.

Infectious Diseases, published by TAYLOR & FRANCIS LTD, is a leading academic journal dedicated to advancing research in the field of infectious diseases and microbiology. With an impressive impact factor and categorized in Q1 in multiple areas including Immunology and Microbiology, this journal serves as a critical platform for researchers, practitioners, and students to disseminate their findings and stay abreast of current advancements. The journal is recognized for its rigorous peer-review process and aims to foster innovation and collaboration across disciplines from 2015 to 2024. It boasts a robust Scopus ranking, positioning it favorably among the top-tier of journals in the relevant fields, making it an essential resource for anyone involved in infectious disease research. Access options are available, ensuring that the latest research is accessible to a global audience, thus emphasizing the journal's commitment to promoting knowledge and understanding in the ever-evolving landscape of infectious diseases.

INFECTION is a prestigious journal, published by Springer Heidelberg, that serves as a leading platform for the dissemination of critical research in the fields of Infectious Diseases, Microbiology, and Medicine. With an impressive Q1 ranking in multiple categories such as Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology, the journal is recognized for its high-quality content and impactful contributions to the scientific community, as evidenced by its Scopus rankings placing it in the top 10th percentiles. Since its inception in 1973, and projected to continue until 2024, INFECTION has established itself as a vital resource for researchers, healthcare professionals, and students keen to explore the latest findings and advancements in infectious diseases. The journal provides a rigorous peer-review process, ensuring that only high-quality studies are published, making it an essential read for those seeking to deepen their understanding and stay abreast of the rapidly evolving landscape in infection research.

Current Infectious Disease Reports, published by SPRINGER, is a leading journal dedicated to advancing knowledge in the field of infectious diseases. With an ISSN of 1523-3847 and an E-ISSN of 1534-3146, this peer-reviewed journal has established itself as a vital resource for researchers and healthcare professionals since its inception in 1999. The journal's impact in the academic community is underscored by its Q1 ranking in Infectious Diseases for 2023, placing it in the top quartile of influential journals in the field. Furthermore, it holds a respectable position at rank #95 out of 344 in the Scopus database, reflecting its substantial contribution to medicine and public health. While currently not an open access journal, it offers a wealth of articles covering the latest research, case studies, and reviews, making it an indispensable tool for those aiming to stay at the forefront of infectious disease science. As we navigate an era marked by emerging and re-emerging infectious threats, Current Infectious Disease Reports remains committed to providing high-quality, relevant research that supports evidence-based practice and informs future studies globally.

The Journal of Global Antimicrobial Resistance, published by Elsevier Scientific Ltd, is a premier open access journal dedicated to addressing the critical issue of antimicrobial resistance on a global scale. Established in 2013 and significantly gaining traction as an open access platform since 2020, this journal serves as an essential resource for researchers, healthcare professionals, and policy makers invested in immunology, microbiology, and associated fields. With an impressive impact factor reflected through its consistent ranking in the Q2 category across multiple disciplines, including Microbiology and Immunology – where it ranks #29 out of 140 in Medical Microbiology – the journal ensures high-quality peer-reviewed articles that push the boundaries of current knowledge and practice. By offering a global perspective on research trends and public health implications, the Journal of Global Antimicrobial Resistance plays a pivotal role in advancing the scientific discourse necessary to combat the rising tide of antimicrobial resistance worldwide.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, published by ELSEVIER SCI LTD, stands as a leading platform in the realm of infectious diseases, contributing significantly to the global understanding of this critical field. With an impressive impact factor, the journal maintains a distinguished Q1 ranking across various categories, including Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology, demonstrating its high relevance and influence among contemporary research. Since its inception in 1996, it has embraced an Open Access model, allowing for wider dissemination of essential research findings that can inform public health policies and clinical practices. With a commitment to advancing scientific knowledge, this journal is not only a vital resource for researchers and professionals but also serves as an invaluable educational tool for students interested in the complexities of infectious diseases and their management. For those looking to stay at the forefront of research and innovation in this field, the INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES is an indispensable resource.

INFECTIOUS DISEASES IN CLINICAL PRACTICE, published by Lippincott Williams & Wilkins, is a crucial resource in the field of infectious diseases and microbiology. With an ISSN of 1056-9103 and an E-ISSN of 1536-9943, this journal has been a platform for scholarly communication since its inception in 1992, now spanning over two decades of continuous publication. The journal primarily focuses on the latest research developments, case studies, and clinical practices relevant to infectious diseases, making it an indispensable tool for researchers, healthcare professionals, and students alike. Although it is currently categorized in the Q4 quartile for both Infectious Diseases and Medical Microbiology, it continues to strive for excellence and relevance in a rapidly evolving field. By facilitating open access to impactful articles (note: Open Access not applicable), the journal aims to enhance global understanding and management of infectious diseases, ensuring that practitioners are well-equipped to confront contemporary challenges in this critical area of public health. Situated in the United States at TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103, INFECTIOUS DISEASES IN CLINICAL PRACTICE plays an essential role in fostering academic discourse and advancing clinical knowledge.

LANCET INFECTIOUS DISEASES is a premier journal published by Elsevier Science Ltd, dedicated to disseminating high-quality research and comprehensive reviews in the field of infectious diseases. Since its inception in 2001, the journal has become a pivotal resource in the medical community, recognized for its rigorous peer-review process and impactful contributions to public health. With an impressive Scopus rank of #2 out of 344 in the category of Medicine - Infectious Diseases, it consistently ranks in the 99th percentile, highlighting its importance and influence in shaping clinical and epidemiological research. The journal's commitment to advancing knowledge in infectious diseases is underscored by its Q1 quartile designation in 2023, affirming its status as a leading academic outlet. Although not an open-access journal, LANCET INFECTIOUS DISEASES provides essential insights for researchers, healthcare professionals, and students, bridging the gap between cutting-edge research and practical application in an increasingly interconnected world.